Drug Profile
Iron isomaltoside 1000 - Pharmacosmos
Alternative Names: Diafer; Iron oligosaccharide; Isofer; Jilazo; Monofer; Monover; NS 32Latest Information Update: 28 Mar 2018
Price :
*
At a glance
- Originator Pharmacosmos
- Developer Cosmopharm; Nippon Shinyaku; Pharmacosmos
- Class Antianaemics; Disaccharides; Ferric compounds
- Mechanism of Action Iron replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Iron deficiency anaemia
- Phase III Metabolic disorders
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for clinical-Phase-Unknown development in Iron deficiency anaemia in Canada (IV, Infusion)
- 28 Mar 2018 No recent reports of development identified for clinical-Phase-Unknown development in Iron deficiency anaemia in Canada (IV, Injection)
- 04 Dec 2017 Registered for Iron deficiency anaemia in Australia (IV)